NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Benefit of Self-monitoring of Anticoagulation Instrument

CompletedNA

Sponsor: University Hospital, Bordeaux

Conditions: Mechanical Prosthetic Heart Valve Implantation, Patient Self Monitoring of Oral Anticoagulent Therapy

Interventions: INRatio / Coaguchek XS

Countries: France

To evaluate the benefit economic and medical of self-monitoring of coagulation compared with conventional follow-up of anticoagulation in a population recently fitted with mechanical heart valves.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* adults
* patients fitted with one or more mechanical heart valves either alone or in combination with myocardial revascularization
* oral anticoagulant treatment
* patients with social security cover
* written informed consent signed by both patient and investigator

Exclusion Criteria:

* women pregnant or liable to become pregnant during the study
* nursing women
* patients unable to master the self-monitoring procedures
* individuals under judicial control or enquiry
* patients consuming excessive amounts of alcohol ((\>40g/j for men et \>30g/j for women femmes ; 1 glass = 10g)
* patients on dialysis
* patients with incomplete understanding of instructions
* blind patients and those unable to read
* presence of circulating anticoagulant

Locations (1)

Pessac, France